Not finding it? Sign in to also search OpenAlex live.
-
Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders2024 Global & Regional Health Technology Assessment article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Alicia Gil, María Reyes Abad Sazatornil, Carmen Alerany, Laia Alsina, Eduardo López Granados, Olaf Neth, +6 more
3citations -
Intradermal substance P as a challenge agent in healthy individuals2023 Clinical and Translational Science article Immunology and Microbiology Mast cells and histamine Open access
Wouter ten Voorde, Chika Akinseye, Ismahaan Abdisalaam, Selinde S. Wind, Naomi B. Klarenbeek, M. Bergmans, +11 more
3citations -
MOTION: A randomized, phase 3, placebo-controlled, double-blind study of vimseltinib (DCC-3014) for the treatment of tenosynovial giant cell tumor.2022 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments cited by 11 patents
William D. Tap, Andrew J. Wagner, Maitreyi G. Sharma, Marc Vallee, Mary F. Michenzie, Matthew Leigh Sherman, +4 more
3citations -
Microstructure-Specific Lifetime Prediction Method for Heavy-Section Castings Based on Non-Destructive Measurements During Fatigue Testing2025 International Journal of Metalcasting article Engineering Fatigue and fracture mechanics Open access
Felix Weber, Tobias Sedlatschek, Alexander Bezold, Christoph Broeckmann, Peter H. Starke
3citations -
Experimental and Numerical Fatigue Life Study of Inner Liner Material in Rocket Combustion Chambers2023 Proceedings - IEEE Aerospace Conference conference-paper Engineering Fatigue and fracture mechanics cited by 1 patent
Pascal H. Kringe, Jörg Riccius, Justin Steven Hardi, Michael Oschwald, Andreas Gernoth, Sebastian Soller, +2 more
3citations -
First experimental test of a coded-mask gamma camera for proton therapy monitoring2025 Physics in Medicine and Biology article Physics and Astronomy Radiation Therapy and Dosimetry Open access
Magdalena Kołodziej, Stephan Brons, George N. Farah, Alexander Fenger, Ronja Hetzel, Jonas Kasper, +10 more
3citations -
An Optimized Crovalimab Dose and Regimen Reduced the Formation of Drug-Target-Drug Complexes in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Phase I/II COMPOSER Trial
Jun‐ichi Nishimura, Antoine Soubret, Simon Buatois, Jean‐Eric Charoin, Sasha Sreckovic, Christoph Marcus Bucher, +21 more
3citations -
Rethinking clinical trials in the multimorbidity era: the imperative for patient-centered tailored approaches2026 Journal of Clinical Epidemiology review Medicine Chronic Disease Management Strategies Open access
Ana Isabel González‐González, Elisa Fabbri, Lara Schürmann, Jeanet W. Blom, Svetlana Puzhko, Amaia Calderón‐Larrañaga, +14 more
3citations -
S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY (“3 + 7”) FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS: A RANDOMIZED PHASE III STUDY OF THE EORTC LEUKEMIA GROUP, GIMEMA, CELG, AND GMDS-SG
M Lübbert, P. W. Wijermans, Michal Kiciński, Sylvain Chantepie, Walter J. F. M. van der Velden, Richard Noppeney, +26 more
3citations -
Attention to the Values, Wishes and Needs of Patients With Advanced Cancer by Hospital Clinicians, an Exploratory Qualitative Study2024 American Journal of Hospice and Palliative Medicine® article Medicine Palliative Care and End-of-Life Issues Open access
Sita de Vries, Laury Pijnappel, Sigrid C. J. M. Vervoort, Yvette M. van der Linden, Saskia C. C. M. Teunissen, Everlien de Graaf
2citations -
Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis2025 British journal of surgery article Medicine Pancreatic and Hepatic Oncology Research Open access
Julia E. Menso, Caro L. Bruna, Mahsoem Ali, Bert A. Bonsing, Koop P Bosscha, Lodewijk A.A. Brosens, +27 more
2citations -
P517 Re-treatment with filgotinib in patients with Ulcerative Colitis following treatment interruption: Analysis of the SELECTION and SELECTIONLTE studies2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Severine A.R.A. Vermeire, Brian G. Feagan, Laurent Peyrin‐Biroulet, Alessandra Faria Oortwijn, Margaux Faes, Gerhard Rogler
2citations -
A Phase 3, Multicenter, Randomized, Open-Label, Active Comparator Conversion Study of Roxadustat in Non-Dialysis-Dependent (NDD) Patients with Anemia in CKD2020 Journal of the American Society of Nephrology conference-abstract Medicine Erythropoietin and Anemia Treatment
Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, Yusuke Yamaguchi
2citations -
Outcomes in patients with advanced gastrointestinal stromal tumor who did not have baseline ctDNA detected in the INTRIGUE study.2023 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
Jonathan C. Trent, Robin L. Jones, Suzanne George, Hans A. J. Gelderblom, Patrick Schöffski, Margaret von Mehren, +13 more
2citations -
Trial in Progress: A Randomized-Controlled Phase 2 Study Evaluating Venetoclax Plus Azacitidine Versus Intensive Chemotherapy in Adult Patients with Newly Diagnosed, NPM1-Mutated AML - the SAL/AMLCG Vincent Trial
Leo Ruhnke, Christoph Schliemann, Lars R. Fransecky, Björn Steffen, Martin Kaufmann, Andreas Burchert, +26 more
2citations -
Ropeginterferon alfa-2b in essential thrombocythemia of all risk levels ineligible for standard cytoreduction: 12-month primary endpoint analysis from the ROP-ET phase 3 study2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Jean‐Jacques Kiladjian, Francesca Palandri, Eloise Beggiato, Alberto Álvarez‐Larrán, Konstanze Döhner, Veronika Buxhofer‐Ausch
2citations